Conference abstract · 15 Mar 2021
Conference abstractPublished 18 Mar 2020
Blockchain In Clinical Research
President of the French Association of Pharmaceutical Medicine, Paris
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
By design or by necessity, clinical trials protocol tend to evolve during the course of the investigation and patients must be kept abreast of any significant change to the protocol and consent in writing to the most recent versions of the protocol. Experience shows that the vast majority of patient adequately consent in writing to participate in a given trial, but that many investigators fail to ask patient to “re-consent” to the amended version of the trial. This can have dramatic consequences, with all the data coming from a clinical center being discarded by the regulators in the analysis To address this risk, Pharmacos and CROs deploy field monitoring resources and auditors to support investigators and detect this type of compliance issues as early as possible. Unfortunately the currently implemented risk-mitigation solutions by CROs only represent a wide-mesh net. Blockchain technology, widely used and validated in the bank and insurance industries does provide an opportunity to address most of these consent management risks, as it provides a mechanism for immutable time-stamping of consent forms, storing and tracking of the forms in a secure and verifiable way. Blockchain technology provides a “single point of truth” for all partners involved in clinical research process, enables real-time synchronization of information between partners, while guaranteeing confidentiality and privacy as shared data can be encrypted. In a time when many stakeholders tend to distrust data and information coming from the Pharmaceutical industry, Blockchain represent an opportunity to provide immutable and unfalsifiable data, hence increased shared trust between pharmaceutical industry and all stakeholders: patients/prescribers/ regulators. Last, it should be mentioned that Blockchain benefits can also be leveraged in pharma supply chain management, contract management, prevention of counterfeiting.
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 24 Apr 2019
Blockchain and the future of genomic ownership & clinical research
Conference abstract · 2019
Implications of blockchain technology on obesity and diabetes: Clinical research and care optimization
Short communication · 29 Apr 2024
Blockchain in Healthcare Applications: Research Challenges and Opportunities
Short communication · 30 Mar 2024
Mapping the Landscape of Blockchain Research in Management and Economics: A Knowledge Visualization Review
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “F.X. Frapaise”
